Search

everythinglearnresearchcommunity

for

Search:↓

High levels of 3 alpha-diol glucuronide in the blood are a marker of increased androgen action in women with excessive hair growth of unknown cause.

Measuring androstanediol glucuronide in blood is useful for assessing and tracking treatment in women with excessive hair growth.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Sebocytes play a key role in controlling androgen levels in human skin.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Finasteride reduces hair growth and is safe for women with excessive hair.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

The main enzyme found in pubic skin that could be targeted to treat excessive hair growth is 5 alpha-R2.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

The exact cause of increased 5α-reductase activity leading to hirsutism in women is still unknown.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

Women with hair loss had higher levels of certain hormones, suggesting a link to a condition like PCOS.

Men with male-pattern baldness have higher levels of certain testosterone metabolites and may have more active androgen metabolism.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

ADT-G may be a useful indicator of increased androgen levels in women with acne and can be lowered with certain birth control pills.

Rodent models of PCOS show some hormone changes similar to humans, but also have key differences.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

Understanding how DHT works is important for diagnosing and treating hormone-related disorders.